ArticleRadiation research2024

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers.

Melissa A Fath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.